Stephens Consulting’s AbbVie ABBV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q4
$334K Buy
1,464
+4
+0.3% +$911 0.11% 48
2025
Q3
$338K Sell
1,460
-318
-18% -$64.8K 0.12% 46
2025
Q2
$330K Sell
1,778
-45
-2% -$8.36K 0.08% 81
2025
Q1
$382K Sell
1,823
-638
-26% -$124K 0.1% 66
2024
Q4
$437K Buy
2,461
+723
+42% +$133K 0.11% 64
2024
Q3
$343K Sell
1,738
-12
-0.7% -$2.24K 0.09% 74
2024
Q2
$300K Buy
1,750
+24
+1% +$3.98K 0.09% 73
2024
Q1
$314K Sell
1,726
-18
-1% -$3.1K 0.1% 68
2023
Q4
$270K Sell
1,744
-32
-2% -$4.67K 0.09% 70
2023
Q3
$265K Sell
1,776
-49
-3% -$7.19K 0.11% 63
2023
Q2
$246K Sell
1,825
-18
-1% -$2.64K 0.1% 67
2023
Q1
$294K Sell
1,843
-130
-7% -$19.9K 0.18% 61
2022
Q4
$319K Sell
1,973
-122
-6% -$18.7K 0.21% 57
2022
Q3
$281K Sell
2,095
-126
-6% -$18.1K 0.25% 56
2022
Q2
$340K Sell
2,221
-24
-1% -$3.67K 0.28% 44
2022
Q1
$364K Sell
2,245
-272
-11% -$39.5K 0.3% 49
2021
Q4
$341K Buy
+2,517
New +$297K 0.29% 60

Other funds holding ABBV